Today's Hospitalist
JUNE 7, 2025
THE BLOCKBUSTER GLP-1 receptor agonists are a transformative class of medications increasingly tied to better outcomes across a variety of conditions and organ systems, not just in patients with obesity and type 2 diabetes. They presented a rapid clinical update Webinar in May 2025 hosted by the Society of Hospital Medicine.
New South Family Medicine and MedSpa
SEPTEMBER 17, 2019
May reduce the risk of heart disease, obesity, and type 2 diabetes. Book your consultation today.","robots":"index","keywords":"biorepeel, Book your consultation today.","robots":"index","keywords":"biorepeel, webinar":{"type":"Static","pageId":"dxdvv"},"./in-the-know":{"type":"Static","pageId":"rp7qt"},"./direct-primary-care":{"type":"Static","pageId":"b42ky"},"./zo-3-step-peel":{"type":"Static","pageId":"xj7v1"},".
Expert insights. Personalized for you.
66 
Let's personalize your content